fda warning letter glp-1 october 2025 Breakdown: Sterility Failures, Subpotent Drugs, and a Compounding Pharmacy Operating Without Control CDER Warning Letters Jump 50%

P = 0.02) (252) and the SELECT trial with semaglutide (HR 0.81

JRNYS itself is not the prescribing entity

If psyllium causes any discomfort, switch to methylcellulose

Prepare smaller, protein-focused portions in advance

Immediate medical attention is necessary if lightheadedness is accompanied by: Chest pain, pressure, or tightness Severe shortness of breath or difficulty breathing Irregular or rapid heartbeat (palpitations) Severe headache, particularly if sudden onset Slurred speech, facial drooping, or weakness on one side of the body Loss of consciousness or fainting episodes Confusion or altered mental status Seizure activity These symptoms may indicate serious cardiovascular or neurological events requiring emergency evaluation